126 related articles for article (PubMed ID: 32960392)
1. Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma.
Jikei K; Ebata T; Mizuno T; Kyokane T; Matsubara H; Yokoyama S; Kato K; Suzumura K; Hashimoto M; Kawai S; Nagino M;
Ann Surg Oncol; 2021 Apr; 28(4):1990-1999. PubMed ID: 32960392
[TBL] [Abstract][Full Text] [Related]
2. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with middle and distal bile duct cancers.
Kwon HJ; Kim SG; Chun JM; Lee WK; Hwang YJ
World J Gastroenterol; 2014 Jun; 20(21):6658-65. PubMed ID: 24914391
[TBL] [Abstract][Full Text] [Related]
4. Middle and distal bile duct carcinoma, retrospective analysis & short-term and long-term outcomes of surgical therapy.
Skalický P; Tesaříková J; Gregořík M; Knápková K; Švébišová H; Kurfúrstová D; Klos D; Loveček M
Rozhl Chir; 2022; 101(9):436-442. PubMed ID: 36257802
[TBL] [Abstract][Full Text] [Related]
5. Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes.
Zhang XF; Zhang N; Tsilimigras DI; Weber SM; Poultsides G; Hatzaras I; Fields RC; He J; Scoggins C; Idrees K; Shen P; Maithel SK; Pawlik TM
J Gastrointest Surg; 2021 Dec; 25(12):3084-3091. PubMed ID: 34131864
[TBL] [Abstract][Full Text] [Related]
6. Surgical Strategies for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma: Bile Duct Resection with or Without Hepatectomy?
Chen RX; Li CX; Luo CH; Zhang H; Zhou T; Wu XF; Wang XH; Li XC
Ann Surg Oncol; 2020 Sep; 27(9):3374-3382. PubMed ID: 32274664
[TBL] [Abstract][Full Text] [Related]
7. Utility of modified pancreaticoduodenectomy (Hi-cut PD) for middle-third cholangiocarcinoma: an alternative to hepatopancreaticoduodenectomy.
Onoe S; Mizuno T; Watanabe N; Yokoyama Y; Igami T; Yamaguchi J; Sunagawa M; Kawakatsu S; Shimoyama Y; Ebata T
HPB (Oxford); 2024 Apr; 26(4):530-540. PubMed ID: 38216429
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
9. Survival Comparison of Different Operation Types for Middle Bile Duct Cancer: Bile Duct Resection versus Pancreaticoduodenectomy Considering Complications and Adjuvant Treatment Effects.
Lim SY; Alramadhan HJ; Jeong H; Chae H; Kim HS; Yoon SJ; Shin SH; Han IW; Heo JS; Kim H
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254787
[TBL] [Abstract][Full Text] [Related]
10. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.
Miyazaki M; Ito H; Nakagawa K; Ambiru S; Shimizu H; Okaya T; Shinmura K; Nakajima N
J Am Coll Surg; 1999 Dec; 189(6):575-83. PubMed ID: 10589594
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients.
Sakamoto Y; Shimada K; Nara S; Esaki M; Ojima H; Sano T; Yamamoto J; Kosuge T
J Gastrointest Surg; 2010 Feb; 14(2):335-43. PubMed ID: 19902311
[TBL] [Abstract][Full Text] [Related]
13. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
Jang JY; Kim SW; Park DJ; Ahn YJ; Yoon YS; Choi MG; Suh KS; Lee KU; Park YH
Ann Surg; 2005 Jan; 241(1):77-84. PubMed ID: 15621994
[TBL] [Abstract][Full Text] [Related]
14. Surgical technique and results of intrapancreatic bile duct resection for hilar malignancy (with video).
Noji T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Tsuchikawa T; Hirano S
HPB (Oxford); 2018 Dec; 20(12):1145-1149. PubMed ID: 29941288
[TBL] [Abstract][Full Text] [Related]
15. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis?
Guilbaud T; Girard E; Lemoine C; Schlienger G; Alao O; Risse O; Berdah S; Chirica M; Moutardier V; Birnbaum DJ
Updates Surg; 2021 Apr; 73(2):439-450. PubMed ID: 33486711
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
[TBL] [Abstract][Full Text] [Related]
17. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.
Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S
Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438
[TBL] [Abstract][Full Text] [Related]
18. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value.
Wang Y; Duan B; Yan L; Shen C; Wu B; Luo J; Shen F; Zhao G
Surgeon; 2016 Feb; 14(1):38-43. PubMed ID: 25263386
[TBL] [Abstract][Full Text] [Related]
20. A multi-institutional analysis of 429 patients undergoing major hepatectomy for colorectal cancer liver metastases: The impact of concomitant bile duct resection on survival.
Postlewait LM; Squires MH; Kooby DA; Weber SM; Scoggins CR; Cardona K; Cho CS; Martin RC; Winslow ER; Maithel SK
J Surg Oncol; 2015 Oct; 112(5):524-8. PubMed ID: 26496211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
